Multiplaintiff ERISA Section 510 Action Filed Against Pharmaceutical Company

United States - New Jersey

Our firm obtained summary judgment on behalf of a global pharmaceutical company in a multiplaintiff ERISA Section 510 action filed in the U.S. District Court of New Jersey and affirmed by the U.S. Third Circuit Court of Appeals.

Results may vary depending on your particular facts and legal circumstances.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.